<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02051816</url>
  </required_header>
  <id_info>
    <org_study_id>131966</org_study_id>
    <nct_id>NCT02051816</nct_id>
  </id_info>
  <brief_title>Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit: The FELLOW Study</brief_title>
  <acronym>FELLOW</acronym>
  <official_title>Facilitating EndotracheaL Intubation by Laryngoscopy Technique and Apneic Oxygenation Within the Intensive Care Unit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Vanderbilt University Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory failure requiring endotracheal intubation occurs in as many as 40% of critically
      ill patients. Procedural complications including failed attempts at intubation, esophageal
      intubation, arterial oxygen desaturation, aspiration, hypotension, cardiac arrest, and death
      are common in this setting. While there are many important components of successful airway
      management in critical illness, the maintenance of adequate arterial hemoglobin saturation
      from procedure initiation until endotracheal tube placement is paramount as desaturation is
      the most common factor associated with peri-intubation cardiac arrest and death.
      Interventions that either shorten the duration of time required for tube placement or prolong
      the period before desaturation may be effective in improving outcome. The high rate of
      complications and the lack of existing evidence regarding the efficacy of current airway
      management techniques in shortening the time to airway establishment or prolonging the time
      to desaturation mandates further investigation. The primary hypothesis is that video
      laryngoscopy will be superior to direct laryngoscopy in successful first attempt at
      endotracheal intubation (defined by confirmed placement of an endotracheal tube in the
      trachea during first laryngoscopy attempt) of medical ICU patients by Pulmonary/Critical Care
      Medicine fellows after controlling for the operator's past number of procedures with the
      equipment used. Also, the investigators hypothesize that the provision of apneic oxygenation
      during the endotracheal intubation procedure (defined as a nasal cannula with 15 liters per
      minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until
      after completion of the procedure) will result in a higher arterial oxygen saturation nadir
      (defined as lowest noninvasive oxygenation saturation value observed between the
      administration of sedation and/or neuromuscular blockade and 2 minutes after successfully
      secured airway or death) compared to no apneic oxygenation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Actual">February 2015</completion_date>
  <primary_completion_date type="Actual">February 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Successful First Attempt at Endotracheal Intubation (Defined by Confirmed Placement of an Endotracheal Tube in the Trachea During First Laryngoscopy Attempt) After Controlling for the Operator's Past Number of Procedures With the Equipment Used.</measure>
    <time_frame>1 hour</time_frame>
    <description>The primary outcome for the video laryngoscopy compared with direct laryngoscopy arm of the study will be the successful first attempt at endotracheal intubation (defined by confirmed placement of an endotracheal tube in the trachea during first laryngoscopy attempt) after controlling for the operator's past number of procedures with the equipment used.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Arterial Oxygen Saturation Nadir (Defined as Lowest Noninvasive Oxygenation Saturation Value Observed Between the Administration of Sedation and/or Neuromuscular Blockade and 2 Minutes After Successfully Secured Airway or Death).</measure>
    <time_frame>1 hour</time_frame>
    <description>The primary outcome for the apneic oxygenation arm of the study is arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Procedure-related Mortality</measure>
    <time_frame>1 hour</time_frame>
    <description>Death within 1 hour of beginning the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU-mortality</measure>
    <time_frame>28 days</time_frame>
    <description>Death from any cause in the ICU and at anytime after the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adjusted Lowest Arterial Oxygen Saturation During Procedure</measure>
    <time_frame>1 hour</time_frame>
    <description>Arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death) adjusted for arterial oxygen saturation at the time of administering intubation drugs.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilator-free Days</measure>
    <time_frame>28 days</time_frame>
    <description>Number of days alive and free of mechanical ventilation after endotracheal intubation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Esophageal Intubations Per Group</measure>
    <time_frame>1 hour</time_frame>
    <description>Number of esophageal intubations Per Study Group</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Grade View of the Glottis</measure>
    <time_frame>1 hour</time_frame>
    <description>Best Cormack-Lehane grade view of the glottis (grade 1-4) on first laryngoscopy attempt. Higher grades on the 1-4 scale indicate worse glottic views.</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Respiratory Failure</condition>
  <arm_group>
    <arm_group_label>VL and AO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Video laryngoscopy and apneic oxygenation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DL and AO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Direct Laryngoscopy and apneic oxygenation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>VL and no AO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Video Laryngoscopy and no apneic oxygenation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DL and no AO</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Direct Laryngoscopy and no apneic oxygenation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Video Laryngoscopy</intervention_name>
    <arm_group_label>VL and no AO</arm_group_label>
    <arm_group_label>DL and no AO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Apneic Oxygenation</intervention_name>
    <arm_group_label>VL and AO</arm_group_label>
    <arm_group_label>DL and AO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Direct Laryngoscopy</intervention_name>
    <arm_group_label>VL and no AO</arm_group_label>
    <arm_group_label>DL and no AO</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>No Apneic Oxygenation</intervention_name>
    <arm_group_label>VL and AO</arm_group_label>
    <arm_group_label>DL and AO</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults

          -  Medical ICU Patients

          -  Require endotracheal intubation

          -  Endotracheal intubation to be performed by Pulmonary/Critical Care Medicine Fellow

          -  Sedation and/or neuromuscular blockade is planned for the procedure

        Exclusion Criteria:

          -  Operators other than Pulmonary/Critical Care Medicine Fellows

          -  The operator predetermines that the patient requires specific intubating equipment or
             oxygenation technique will be required for the safe performance of the procedure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matthew W Semler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Todd W Rice, MD, MSc</last_name>
    <role>Study Chair</role>
    <affiliation>Vanderbilt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 27, 2014</study_first_submitted>
  <study_first_submitted_qc>January 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 31, 2014</study_first_posted>
  <results_first_submitted>July 6, 2016</results_first_submitted>
  <results_first_submitted_qc>April 19, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">May 24, 2017</results_first_posted>
  <last_update_submitted>April 19, 2017</last_update_submitted>
  <last_update_submitted_qc>April 19, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 24, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt University</investigator_affiliation>
    <investigator_full_name>David Janz</investigator_full_name>
    <investigator_title>Clinical Fellow</investigator_title>
  </responsible_party>
  <keyword>Endotracheal Intubation</keyword>
  <keyword>Apneic Oxygenation</keyword>
  <keyword>Respiratory failure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Video Laryngoscopy and No Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
        </group>
        <group group_id="P2">
          <title>Direct Laryngoscopy and Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
        </group>
        <group group_id="P3">
          <title>Video Laryngoscopy and Apneic Oxygenation</title>
          <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
        </group>
        <group group_id="P4">
          <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
          <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="37"/>
                <participants group_id="P4" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="40"/>
                <participants group_id="P3" count="37"/>
                <participants group_id="P4" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Video Laryngoscopy and Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
and
A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure</description>
        </group>
        <group group_id="B2">
          <title>Direct Laryngoscopy and Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
and
A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure</description>
        </group>
        <group group_id="B3">
          <title>Video Laryngoscopy and no Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
and
No apneic oxygenation</description>
        </group>
        <group group_id="B4">
          <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
and
No apneic oxygenation</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="40"/>
            <count group_id="B3" value="37"/>
            <count group_id="B4" value="36"/>
            <count group_id="B5" value="150"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="58" spread="15"/>
                    <measurement group_id="B2" value="58" spread="14"/>
                    <measurement group_id="B3" value="56" spread="15"/>
                    <measurement group_id="B4" value="58" spread="12"/>
                    <measurement group_id="B5" value="58" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="15"/>
                    <measurement group_id="B5" value="59"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="22"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="25"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="7"/>
                    <measurement group_id="B3" value="6"/>
                    <measurement group_id="B4" value="3"/>
                    <measurement group_id="B5" value="19"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="30"/>
                    <measurement group_id="B4" value="32"/>
                    <measurement group_id="B5" value="125"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                    <measurement group_id="B5" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="1"/>
                    <measurement group_id="B5" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="37"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="37"/>
                    <measurement group_id="B4" value="36"/>
                    <measurement group_id="B5" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29" spread="8"/>
                    <measurement group_id="B2" value="29" spread="9"/>
                    <measurement group_id="B3" value="28" spread="5"/>
                    <measurement group_id="B4" value="29" spread="8"/>
                    <measurement group_id="B5" value="29" spread="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Acute Physiology and Chronic Health Evaluation II Score</title>
          <description>range of scale is minimum 0 - maximum 100 lower values describe less acute/chronic illness and more likely to survive higher values describe more acute/chronic illness and less likely to survive</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21" spread="9"/>
                    <measurement group_id="B2" value="21" spread="6"/>
                    <measurement group_id="B3" value="23" spread="6"/>
                    <measurement group_id="B4" value="21" spread="6"/>
                    <measurement group_id="B5" value="21" spread="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Successful First Attempt at Endotracheal Intubation (Defined by Confirmed Placement of an Endotracheal Tube in the Trachea During First Laryngoscopy Attempt) After Controlling for the Operator’s Past Number of Procedures With the Equipment Used.</title>
        <description>The primary outcome for the video laryngoscopy compared with direct laryngoscopy arm of the study will be the successful first attempt at endotracheal intubation (defined by confirmed placement of an endotracheal tube in the trachea during first laryngoscopy attempt) after controlling for the operator’s past number of procedures with the equipment used.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy
Direct Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Video Laryngoscopy
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Successful First Attempt at Endotracheal Intubation (Defined by Confirmed Placement of an Endotracheal Tube in the Trachea During First Laryngoscopy Attempt) After Controlling for the Operator’s Past Number of Procedures With the Equipment Used.</title>
          <description>The primary outcome for the video laryngoscopy compared with direct laryngoscopy arm of the study will be the successful first attempt at endotracheal intubation (defined by confirmed placement of an endotracheal tube in the trachea during first laryngoscopy attempt) after controlling for the operator’s past number of procedures with the equipment used.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="51"/>
                    <measurement group_id="O2" value="50"/>
                    <measurement group_id="O3" value="NA">See apneic oxygenation separate outcomes</measurement>
                    <measurement group_id="O4" value="NA">See apneic oxygenation separate outcomes</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Arterial Oxygen Saturation Nadir (Defined as Lowest Noninvasive Oxygenation Saturation Value Observed Between the Administration of Sedation and/or Neuromuscular Blockade and 2 Minutes After Successfully Secured Airway or Death).</title>
        <description>The primary outcome for the apneic oxygenation arm of the study is arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death).</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy
Direct Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Video Laryngoscopy
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Arterial Oxygen Saturation Nadir (Defined as Lowest Noninvasive Oxygenation Saturation Value Observed Between the Administration of Sedation and/or Neuromuscular Blockade and 2 Minutes After Successfully Secured Airway or Death).</title>
          <description>The primary outcome for the apneic oxygenation arm of the study is arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death).</description>
          <units>percent arterial oxygen saturation</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="74"/>
                <count group_id="O2" value="76"/>
                <count group_id="O3" value="77"/>
                <count group_id="O4" value="73"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="NA">See video laryngoscopy outcomes separately</measurement>
                    <measurement group_id="O2" value="NA">See video laryngoscopy outcomes separately</measurement>
                    <measurement group_id="O3" value="92" lower_limit="84" upper_limit="99"/>
                    <measurement group_id="O4" value="90" lower_limit="80" upper_limit="96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Procedure-related Mortality</title>
        <description>Death within 1 hour of beginning the procedure</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Procedure-related Mortality</title>
          <description>Death within 1 hour of beginning the procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                    <measurement group_id="O4" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ICU-mortality</title>
        <description>Death from any cause in the ICU and at anytime after the procedure</description>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>ICU-mortality</title>
          <description>Death from any cause in the ICU and at anytime after the procedure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="15"/>
                    <measurement group_id="O3" value="12"/>
                    <measurement group_id="O4" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adjusted Lowest Arterial Oxygen Saturation During Procedure</title>
        <description>Arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death) adjusted for arterial oxygen saturation at the time of administering intubation drugs.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Adjusted Lowest Arterial Oxygen Saturation During Procedure</title>
          <description>Arterial oxygen saturation nadir (defined as lowest noninvasive oxygenation saturation value observed between the administration of sedation and/or neuromuscular blockade and 2 minutes after successfully secured airway or death) adjusted for arterial oxygen saturation at the time of administering intubation drugs.</description>
          <units>PERCENT SATURATION</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="88" spread="12"/>
                    <measurement group_id="O2" value="89" spread="12"/>
                    <measurement group_id="O3" value="87" spread="12"/>
                    <measurement group_id="O4" value="82" spread="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Ventilator-free Days</title>
        <description>Number of days alive and free of mechanical ventilation after endotracheal intubation</description>
        <time_frame>28 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Ventilator-free Days</title>
          <description>Number of days alive and free of mechanical ventilation after endotracheal intubation</description>
          <units>DAYS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" spread="12"/>
                    <measurement group_id="O2" value="12" spread="12"/>
                    <measurement group_id="O3" value="14" spread="12"/>
                    <measurement group_id="O4" value="11" spread="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Esophageal Intubations Per Group</title>
        <description>Number of esophageal intubations Per Study Group</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Esophageal Intubations Per Group</title>
          <description>Number of esophageal intubations Per Study Group</description>
          <units>number of esophageal intubations</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                    <measurement group_id="O4" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Grade View of the Glottis</title>
        <description>Best Cormack-Lehane grade view of the glottis (grade 1-4) on first laryngoscopy attempt. Higher grades on the 1-4 scale indicate worse glottic views.</description>
        <time_frame>1 hour</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Video Laryngoscopy and No Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
No Apneic Oxygenation</description>
          </group>
          <group group_id="O2">
            <title>Direct Laryngoscopy and Apneic Oxygenation</title>
            <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation</description>
          </group>
          <group group_id="O3">
            <title>Video Laryngoscopy and Apneic Oxygenation</title>
            <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy</description>
          </group>
          <group group_id="O4">
            <title>Direct Laryngoscopy and No Apneic Oxygenation</title>
            <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Direct Laryngoscopy</description>
          </group>
        </group_list>
        <measure>
          <title>Grade View of the Glottis</title>
          <description>Best Cormack-Lehane grade view of the glottis (grade 1-4) on first laryngoscopy attempt. Higher grades on the 1-4 scale indicate worse glottic views.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="40"/>
                <count group_id="O3" value="37"/>
                <count group_id="O4" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.24" spread=".43"/>
                    <measurement group_id="O2" value="1.8" spread="1.09"/>
                    <measurement group_id="O3" value="1.3" spread=".66"/>
                    <measurement group_id="O4" value="1.75" spread=".77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Video Laryngoscopy</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of McGrath® video laryngoscope, GlideScope® video laryngoscope, or bronchoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
        </group>
        <group group_id="E2">
          <title>Direct Laryngoscopy</title>
          <description>Patients randomized to undergo endotracheal intubation using the operator's choice of a MacIntosh or Miller blade direct laryngoscope.
Apneic Oxygenation
No Apneic Oxygenation</description>
        </group>
        <group group_id="E3">
          <title>Apneic Oxygenation</title>
          <description>A nasal cannula with 15 liters per minute of oxygen flow placed prior to sedation or neuromuscular blockade and maintained until after completion of the procedure
Video Laryngoscopy
Direct Laryngoscopy</description>
        </group>
        <group group_id="E4">
          <title>No Apneic Oxygenation</title>
          <description>No nasal cannula, supplemental oxygen given after sedation or neuromuscular blockade until completion of the procedure.
Video Laryngoscopy
Direct Laryngoscopy</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="73"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="74"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="76"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="77"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="73"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>David Janz, MD, MSc</name_or_title>
      <organization>LSU School of Medicine New Orleans</organization>
      <phone>504-568-3167</phone>
      <email>djanz@lsuhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

